Given the established link between defective DNA repair and tumorigenesis, further studies are warranted to elucidate how SIRT6 dysfunction contributes to specific cancer types, and whether pharmacological activation of SIRT6 can be translated into clinically meaningful strategies for cancer prevention and therapy. Here, SIRT6 is linked to cancer.